Skip to search formSkip to main contentSkip to account menu

Neuroprotective Agents

Known as: Neuroprotectants, Neuroprotective Agent, neuroprotective drug 
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the… 
National Institutes of Health

Related topics

Related topics

49 relations

Narrower (42)

1-aminocyclopropane-1-carboxylic acid3-aminobenzamide3-n-butylphthalide4-carboxy-3-hydroxyphenylglycine
ChemopreventionIn Bloodagonistsantagonists & inhibitors

Broader (1)

neuropharmacologic agent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
Review
2003
Review
2003
Tryptophan Metabolites and Brain Disorders
Abstract Tryptophan is metabolised primarily along the kynurenine pathway, of which two components are now known to have marked… 
Highly Cited
2003
Highly Cited
2003
Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
Transgenic Drosophila expressing human alpha-synuclein faithfully replicate essential features of human Parkinson's disease… 
Review
2001
Review
2001
Endogenous neurotoxins from tryptophan.
Highly Cited
2001
Highly Cited
2001
Pharmacological modulation of SK3 channels
Highly Cited
2000
Highly Cited
2000
Identification of Kaempferol as a Monoamine Oxidase Inhibitor and Potential Neuroprotectant in Extracts of Ginkgo Biloba Leaves
The effects of Ginkgo biloba leaf extract on rat brain or livermonoamine oxidase (MAO)‐A and ‐B activity, biogenic amine… 
Review
1999
Review
1999
Role and mechanisms of secondary mitochondrial failure.
Ischemia is accompanied by mitochondrial dysfunction, as assessed by measurements of mitochondrial respiratory activities in… 
Review
1999
Review
1999
Drug development for stroke: importance of protecting cerebral white matter.
Review
1997
Review
1997
Role of adenosine as a modulator of synaptic activity in the central nervous system.
Review
1991
Review
1991
Physiological and pharmacological properties of adenosine: therapeutic implications.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)